pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3170 |
Genomic Coordinates | chr13: 98208524 - 98208600 |
Description | Homo sapiens miR-3170 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3170 | |||||||||||||||||||||||||||
Sequence | 10| CUGGGGUUCUGAGACAGACAGU |31 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UBE2S | ||||||||||||||||||||
Synonyms | E2-EPF, E2EPF, EPF5 | ||||||||||||||||||||
Description | ubiquitin conjugating enzyme E2 S | ||||||||||||||||||||
Transcript | NM_014501 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UBE2S | |||||||||||||||||||||
3'UTR of UBE2S (miRNA target sites are highlighted) |
>UBE2S|NM_014501|3'UTR 1 TGGGCTCTCTTCCTCCTTCCACCGTGACCCCAACCTCTCCTGTCCCCTCCCTCCAACTCTGTCTCTAAGTTATTTAAATT 81 ATGGCTGGGGTCGGGGAGGGTACAGGGGGCACTGGGACCTGGATTTGTTTTTCTAAATAAAGTTGGAAAAGCAGAAAAAA 161 AAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000264552.9 | 3UTR | CUCUCUUCCUCCUUCCACCGUGACCCCAACCUCUCCUGUCCCCUCCCUCCAACUCUGUCUCUAAGUUAUUUAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-miR-3170 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT074402 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT114937 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT248326 | HOXC8 | homeobox C8 | 2 | 2 | ||||||||
MIRT329432 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 2 | ||||||||
MIRT460868 | UBE2S | ubiquitin conjugating enzyme E2 S | 2 | 2 | ||||||||
MIRT464626 | UBE4A | ubiquitination factor E4A | 2 | 2 | ||||||||
MIRT466225 | TMED10 | transmembrane p24 trafficking protein 10 | 2 | 2 | ||||||||
MIRT473424 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT473514 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT475798 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478032 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT482963 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT485905 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 6 | ||||||||
MIRT488146 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT491777 | ZNF24 | zinc finger protein 24 | 2 | 2 | ||||||||
MIRT493023 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT502199 | HSPB8 | heat shock protein family B (small) member 8 | 2 | 2 | ||||||||
MIRT505367 | TMEM154 | transmembrane protein 154 | 2 | 4 | ||||||||
MIRT505919 | RCAN3 | RCAN family member 3 | 2 | 4 | ||||||||
MIRT509089 | SYNPO2L | synaptopodin 2 like | 2 | 4 | ||||||||
MIRT509103 | BMP8B | bone morphogenetic protein 8b | 2 | 6 | ||||||||
MIRT509571 | HIST2H2AB | histone cluster 2 H2A family member b | 2 | 4 | ||||||||
MIRT509782 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511295 | KIAA1551 | KIAA1551 | 2 | 2 | ||||||||
MIRT514289 | FXYD5 | FXYD domain containing ion transport regulator 5 | 2 | 6 | ||||||||
MIRT514389 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT514404 | RSL1D1 | ribosomal L1 domain containing 1 | 2 | 2 | ||||||||
MIRT514421 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT514546 | PTGR2 | prostaglandin reductase 2 | 2 | 2 | ||||||||
MIRT514790 | SLC25A45 | solute carrier family 25 member 45 | 2 | 2 | ||||||||
MIRT514836 | LYRM7 | LYR motif containing 7 | 2 | 2 | ||||||||
MIRT514850 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 2 | ||||||||
MIRT515112 | LMOD3 | leiomodin 3 | 2 | 2 | ||||||||
MIRT515338 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT515582 | FBXL13 | F-box and leucine rich repeat protein 13 | 2 | 4 | ||||||||
MIRT515612 | ISY1 | ISY1 splicing factor homolog | 2 | 2 | ||||||||
MIRT516018 | A1CF | APOBEC1 complementation factor | 2 | 2 | ||||||||
MIRT516721 | MYPN | myopalladin | 2 | 2 | ||||||||
MIRT516739 | GSTK1 | glutathione S-transferase kappa 1 | 2 | 2 | ||||||||
MIRT516774 | PTRF | caveolae associated protein 1 | 2 | 4 | ||||||||
MIRT517076 | C3orf62 | chromosome 3 open reading frame 62 | 2 | 2 | ||||||||
MIRT517115 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT517196 | OTUD6A | OTU deubiquitinase 6A | 2 | 2 | ||||||||
MIRT517321 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT517612 | DEGS1 | delta 4-desaturase, sphingolipid 1 | 2 | 2 | ||||||||
MIRT517626 | ZNF491 | zinc finger protein 491 | 2 | 2 | ||||||||
MIRT517656 | TRIM72 | tripartite motif containing 72 | 2 | 4 | ||||||||
MIRT517742 | DIS3L | DIS3 like exosome 3'-5' exoribonuclease | 2 | 4 | ||||||||
MIRT518002 | RPL4 | ribosomal protein L4 | 2 | 4 | ||||||||
MIRT518165 | FGB | fibrinogen beta chain | 2 | 2 | ||||||||
MIRT518180 | SLC27A4 | solute carrier family 27 member 4 | 2 | 2 | ||||||||
MIRT518555 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 2 | 2 | ||||||||
MIRT518572 | ATP8B1 | ATPase phospholipid transporting 8B1 | 2 | 2 | ||||||||
MIRT519008 | NOA1 | nitric oxide associated 1 | 2 | 2 | ||||||||
MIRT519340 | CACNG1 | calcium voltage-gated channel auxiliary subunit gamma 1 | 2 | 2 | ||||||||
MIRT519363 | RBM28 | RNA binding motif protein 28 | 2 | 2 | ||||||||
MIRT519388 | DNASE2 | deoxyribonuclease 2, lysosomal | 2 | 4 | ||||||||
MIRT519404 | KCNA7 | potassium voltage-gated channel subfamily A member 7 | 2 | 4 | ||||||||
MIRT519615 | ZNF788 | zinc finger family member 788 | 2 | 4 | ||||||||
MIRT519817 | ZKSCAN4 | zinc finger with KRAB and SCAN domains 4 | 2 | 2 | ||||||||
MIRT520455 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT520761 | TCF23 | transcription factor 23 | 2 | 2 | ||||||||
MIRT520981 | SOCS5 | suppressor of cytokine signaling 5 | 2 | 2 | ||||||||
MIRT521275 | RTF1 | RTF1 homolog, Paf1/RNA polymerase II complex component | 2 | 2 | ||||||||
MIRT521397 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 2 | 2 | ||||||||
MIRT522023 | PAQR3 | progestin and adipoQ receptor family member 3 | 2 | 4 | ||||||||
MIRT522105 | NUDT3 | nudix hydrolase 3 | 2 | 2 | ||||||||
MIRT522145 | NR2F6 | nuclear receptor subfamily 2 group F member 6 | 2 | 4 | ||||||||
MIRT522219 | NPFFR1 | neuropeptide FF receptor 1 | 2 | 2 | ||||||||
MIRT522274 | NKAP | NFKB activating protein | 2 | 2 | ||||||||
MIRT522639 | MANEAL | mannosidase endo-alpha like | 2 | 2 | ||||||||
MIRT523167 | HIST3H3 | histone cluster 3 H3 | 2 | 2 | ||||||||
MIRT523497 | GMPS | guanine monophosphate synthase | 2 | 4 | ||||||||
MIRT524033 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | 2 | 2 | ||||||||
MIRT524396 | COQ10B | coenzyme Q10B | 2 | 2 | ||||||||
MIRT524682 | C12orf49 | chromosome 12 open reading frame 49 | 2 | 2 | ||||||||
MIRT525542 | PHB2 | prohibitin 2 | 2 | 4 | ||||||||
MIRT528430 | COL9A2 | collagen type IX alpha 2 chain | 2 | 2 | ||||||||
MIRT528738 | RAB13 | RAB13, member RAS oncogene family | 2 | 2 | ||||||||
MIRT530944 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT531653 | ZFP14 | ZFP14 zinc finger protein | 2 | 2 | ||||||||
MIRT531851 | MAP2K2 | mitogen-activated protein kinase kinase 2 | 2 | 2 | ||||||||
MIRT533473 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT533658 | TMF1 | TATA element modulatory factor 1 | 2 | 2 | ||||||||
MIRT540966 | ZNF8 | zinc finger protein 8 | 2 | 2 | ||||||||
MIRT541988 | MYO1C | myosin IC | 2 | 2 | ||||||||
MIRT549545 | CLPP | caseinolytic mitochondrial matrix peptidase proteolytic subunit | 2 | 2 | ||||||||
MIRT551722 | PCYT1A | phosphate cytidylyltransferase 1, choline, alpha | 2 | 2 | ||||||||
MIRT553984 | SRPR | SRP receptor alpha subunit | 2 | 2 | ||||||||
MIRT555113 | PUM2 | pumilio RNA binding family member 2 | 2 | 2 | ||||||||
MIRT563172 | ZRANB3 | zinc finger RANBP2-type containing 3 | 2 | 2 | ||||||||
MIRT564006 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 2 | ||||||||
MIRT564445 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT565959 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT607541 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT607685 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 2 | ||||||||
MIRT609323 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT614038 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT616763 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT619706 | C6orf132 | chromosome 6 open reading frame 132 | 2 | 2 | ||||||||
MIRT619955 | CLN8 | CLN8, transmembrane ER and ERGIC protein | 2 | 2 | ||||||||
MIRT625229 | C6orf89 | chromosome 6 open reading frame 89 | 2 | 2 | ||||||||
MIRT634238 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT634964 | C8orf17 | chromosome 8 open reading frame 17 | 2 | 2 | ||||||||
MIRT639615 | FGF19 | fibroblast growth factor 19 | 2 | 2 | ||||||||
MIRT642692 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT643689 | KIAA0586 | KIAA0586 | 2 | 2 | ||||||||
MIRT645271 | SLC38A5 | solute carrier family 38 member 5 | 2 | 2 | ||||||||
MIRT647340 | RPH3AL | rabphilin 3A like (without C2 domains) | 2 | 2 | ||||||||
MIRT648167 | TMEM192 | transmembrane protein 192 | 2 | 2 | ||||||||
MIRT655464 | PAK3 | p21 (RAC1) activated kinase 3 | 2 | 2 | ||||||||
MIRT660232 | BMP7 | bone morphogenetic protein 7 | 2 | 2 | ||||||||
MIRT666181 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 2 | ||||||||
MIRT673638 | CYCS | cytochrome c, somatic | 2 | 2 | ||||||||
MIRT674044 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT691167 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT711724 | NUPL2 | nucleoporin like 2 | 2 | 2 | ||||||||
MIRT712404 | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase | 2 | 2 | ||||||||
MIRT715537 | FTCD | formimidoyltransferase cyclodeaminase | 2 | 2 | ||||||||
MIRT715939 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT722976 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|